Ned Jannotta

From SourceWatch
Jump to navigation Jump to search
This article is a stub. You can help by expanding it.

Biographical Details

"Ned Jannotta began his career as an associate with GTCR in 1985. After spending three years with GTCR, he left to join William Blair Capital Partners, where he was a managing director for over nine years. He rejoined GTCR in 1998 and became managing principal in 2002. Mr. Jannotta holds an AB in Politics, cum laude, from Princeton University and an MBA from Harvard University.

"Mr. Jannotta is a director of Chester Valley Pharmaceuticals, ForeFront Education, GeneraMedix Pharmaceuticals, Morton Grove Pharmaceuticals, Ovation Pharmaceuticals, and Trans Healthcare. In addition, Mr. Jannotta was a director and played a key role in GTCR's highly successful past investments in CuraScript and LifeCare Management Services." [1]

  • Policy Advisory Board, ONE Campaign (former member 2010 at least)

Resources and articles

Related Sourcewatch


  1. Policy Advisory Board, ONE Campaign, accessed January 7, 2011.